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Adoptive cell transfer of ex vivo-generated immune-promoting
or tolerogenic T cells to either enhance immunity or promote tolerance
in patients has been used with some success. However, effective
trafficking of the transferred cells to the target tissue sites is the main
barrier to achieving successful clinical outcomes. Here we developed
a strategy for optically controlling T-cell trafficking using a photo-
activatable (PA) chemokine receptor. Photoactivatable-chemokine
C-X-C motif receptor 4 (PA-CXCR4) transmitted intracellular CXCR4
signals in response to 505-nm light. Localized activation of PA-
CXCR4 induced T-cell polarization and directional migration (photo-
taxis) both in vitro and in vivo. Directing light onto the melanoma
was sufficient to recruit PA-CXCR4–expressing tumor-targeting cy-
totoxic T cells and improved the efficacy of adoptive T-cell transfer
immunotherapy, with a significant reduction in tumor growth in
mice. These findings suggest that the use of photoactivatable che-
mokine receptors allows remotely controlled leukocyte traffick-
ing with outstanding spatial resolution in tissues and may be
feasible in other cell transfer therapies.
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The chemokine family performs a central function in leukocytemigration because it includes major players in the determi-
nation of tissue-specificity and selectivity during leukocyte re-
cruitment. A number of fundamental pathophysiological processes
are dependent on chemokine-mediated cell migration, including
inflammation and cancer metastasis. However, therapies aimed at
controlling cell migration by manipulating specific chemokine sig-
nals have been limited.
T-cell–based immunotherapy has emerged as a powerful treat-
ment option for several disease conditions, including patients with
unresectable stage III and IV metastatic melanoma (1). The ef-
ficacy of adoptive cell transfer (ACT) in cancer immunotherapy
and clinical response rates are strongly correlated to the number
of adoptively transferred T cells that infiltrate the tumor micro-
environment (2), but the trafficking efficiency of transferred
T cells is extremely low (3, 4). Although the intratumoral delivery
of a chemokine-encoding system has been proposed to enhance
cytotoxic T cell (CTL) homing to the tumor site (5), chemokines
directly contribute to tumor growth, metastasis, and angiogenesis
(6). Thus, to selectively and precisely control chemokine signal
and migration of T cells in vivo, we developed a photoactivatable
chemokine receptor that transmits intracellular chemokine signals
and guides cell migration both in vitro and in vivo in response to
localized stimulation with a specific wavelength of light.
Results
Engineering of Photoactivatable Chemokine C-X-C Motif Receptor 4.
To enable the phototactic migration of T cells, we took advan-
tage of the shared structure–function relationships of G protein
coupled receptors (GPCRs) to develop and express a rhodopsin-
chemokine receptor chimera with a transduction mechanism that
couples an extracellular optical signal to intracellular chemokine
effector functions. Based on previously published structural
models (7, 8), photoactivatable chemokine receptor CXCR4 (PA-
CXCR4) chimera was carefully designed to swap the G protein
functions of rhodopsin-coupled Gαt with CXCR4-associated Gαi
and to optimize surface expression in mammalian cells (Fig. 1 A
and C). The t1/2 value of rhodopsin chromophore formation
(A500) is 2.7 min with 3.3 μM 11-cis-retinal (9), and both human
blood and mouse blood contain ∼1 μM retinol (10, 11), enabling
the use of the opsin-receptor chimera as a new class of in vivo
immunological tools that does not require supplementation with
exogenous retinal cofactors.
A 3D model for the retinal-bound PA-CXCR4 structure
revealed no major rearrangement in the retinal-binding pocket
compared with WT rhodopsin (Fig. S1) (12, 13). This finding
suggests that the transmembrane domains of PA-CXCR4, which
originated from rhodopsin, compensate for the structural and
mechanical stresses resulting from the chimeric design and that
the bulky side chains around retinal are not significantly affected
by the CXCR4 cytoplasmic domains. Transient transfections of
PA-CXCR4-mCherry into human and mouse T cells further
confirmed the successful expression of the construct at the plasma
membrane (Fig. 1B and Fig. S2).
Optical Control of Chemokine Receptor Signal Transduction. One of
the earliest events after chemokine stimulation is a transient
increase in the intracellular Ca2+ concentration ([Ca2+]i). To test
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the functional responses of PA-CXCR4, we imaged [Ca2+]i in
mouse T cells transfected with PA-CXCR4. Fluorescence
imaging of [Ca2+]i demonstrated that stimulation with green light
(488 ± 10 nm, 4.00 mW) was sufficient to drive prominent
downstream [Ca2+]i signals in PA-CXCR4–expressing cells but
not in wild-type control cells (WT CXCR4), indicating the
functional expression of PA-CXCR4 (Fig. 2A, Movie S1, and
Fig. S3). CXCL12 binds to CXCR4 and activates G protein-
mediated signaling through the Gαi pathway, which reduces cy-
clic adenosine monophosphate (cAMP) levels within cells. To
further test the specific chemokine signals controlled by PA-
CXCR4, HEK293 cells (Fig. 2B) or mouse T cells (Fig. 2C)
expressing WT CXCR4 or PA-CXCR4 were stimulated with
forskolin, and decreases in forskolin-induced cAMP produc-
tion were then measured after CXCL12 treatment (for WT
CXCR4) or excitation with 505-nm light (for PA-CXCR4).
Optical stimulation yielded a significant decrease in forskolin-
induced cAMP production comparable to that achieved by
CXCL12 stimulation of WT CXCR4 (Fig. 2 B and C). The cells
remained nonresponsive when illuminated with wavelengths
longer than rhodopsin absorbance (535 or 635 nm) (Fig. 2C). We
also observed protein kinase Akt and serine/threonine-protein
kinase PAK1 activation (phosphorylation), which are parts of
another canonical CXCR4 signaling pathway that is critical for
CXCL12-mediated cell migration. The phosphorylation of Akt
and PAK1 peaked between 3 and 20 min following light stimu-
lation of PA-CXCR4–expressing mouse T cells. The trend was
similar to what was observed in WT cells treated with CXCL12
(Fig. 2D). CXCR4 can also stimulate Rho kinase and phos-
phorylate myosin light chain (MLC) through the Gα12/13 pathway
(14). The phosphorylation of MLC was observed following light
stimulation of PA-CXCR4–exrepssing HEK293 cells, similar to
what was shown in WT CXCR4-expressing cells treated with
CXCL12 (Fig. S4). However, optical stimulation of blue opsin-
expressing cells failed to induce significant phosphorylation of
MLC, suggesting that unlike PA-CXCR4, light-induced activa-
tion of blue opsin GPCR signals is not mediated by Gα12/13 (15).
Important functions of CXCR4 critically depend on its cell sur-
face expression, which is regulated by receptor endocytosis, in-
tracellular trafficking, and recycling. Treatment of T cells with
CXCL12 induced the endocytosis of surface WT CXCR4 (re-
ceptor desensitization), which was reversed by removing the ex-
tracellular CXCL12 (Fig. S5). Consistently, illumination of
Fig. 1. Engineering of photoactivatable CXCR4 (PA-CXCR4). (A) PA-CXCR4
design. Rhod, rhodopsin. (B) Expression of PA-CXCR4-mCherry in human
primary T cells. (C) Primary structure alignment of WT rhodopsin, WT CXCR4,
and PA-CXCR4. Green, highly conserved residues; cyan, swapped intracellular
domains (Nt, N terminus; TM, transmembrane domain; IL, intracellular loop;
EL, extracellular loop; Ct, C terminus).
Fig. 2. Characterization of PA-CXCR4. (A) Fluo-4 Ca2+ imaging. Intensity traces
of mouse OT-I CD8 T cells (WT CXCR4) and cells transiently transfected with PA-
CXCR4-mCherry (PA-CXCR4). The cells were stimulated with CXCL12 or 488-nm
light, followed by a Ca2+ ionophore. For the PA-CXCR4–expressing cells, the Ca2+
traces were measured only in positive transfectants (white circles; Movie S1).
PA-CXCR4, n = 5; WT CXCR4, n = 32. Mean ± SEM. (B) The inhibition of for-
skolin-induced cAMP production in HEK 293 cells. *P < 0.05 compared with
forskolin alone (mean ± SEM, n = 3). (C) The inhibition of forskolin-induced
cAMP production in mouse T cells expressing mCherry or PA-CXCR4-mCherry
(PA-CXCR4). Optical stimulations were performed with indicated wavelengths.
*P < 0.05 compared with forskolin alone (mean ± SEM, n = 3). (D) Immunoblots
from mouse OT-I CD8 T cells (CXCR4) and cells transiently transfected with PA-
CXCR4-mCherry (PA-CXCR4) were probed for phosphorylated (pAkt; pThr308,
and pPAK1) and total Akt and PAK1. Densitometric analysis of pAkt and pPAK1
were normalized to total protein levels and expressed as mean fold increase
compared with control (time = 0 min). Data are expressed as mean ± SEM from
three independent experiments. *P < 0.05.
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PA-CXCR4 expressing T cells with 505-nm light decreased the
cell surface levels of PA-CXCR4, whereas removal of the light
stimulation restored the surface expression (Fig. S5).
Activation of PA-CXCR4 Induces T-Cell Polarization and Migration in
Vitro. We next used PA-CXCR4 to determine if localized che-
mokine activation is sufficient to induce T-cell polarization.
Mouse T cells expressing GFP remained quiescent when il-
luminated with 505-nm light (Fig. S6 and Movie S2). In contrast,
the repeated illumination of PA-CXCR4–expressing T cells led
first to lamellipodial protrusions and membrane ruffles around
the cell edges and then to complete cell polarization (Fig. 3A and
Movie S3). To determine the specific effects of PA-CXCR4 on
T-cell polarization, kymographs were used to quantify the max-
imum protrusion length. Illumination of PA-CXCR4 elicited
membrane protrusions that were significantly longer than those
observed in the cells expressing GFP (Fig. 3B). Most of the light-
induced lamellipodial generations in PA-CXCR4–expressing
cells occurred in the near-perpendicular direction (angles be-
tween ±45°) relative to the point of illumination, whereas the
spontaneous membrane protrusions were formed in random
directions in GFP-expressing T cells (Fig. 3B). Rap1, a member
of the Ras family of small GTPases, modulates T-cell polariza-
tion and integrin activation during migration (16). A Rap1
Raichu fluorescence resonance energy transfer (FRET) sensor
(17) revealed that the stimulation of CXCR4 signals in a spatially
confined area of the cell led to rapid, localized Rap1 activation
that did not readily spread outward from the illuminated spot
(Fig. 3C and Movie S4). Therefore, Rap1 activation appears
to be compartmentalized near chemokine signals, suggesting
a polarized distribution of Rap1 activation toward a chemokine
gradient during cell migration. Pretreatment of the cells with
pertussis toxin (PTX) completely abolished PA-CXCR4–induced
Rap1 activation (Movie S5).
The primary function of chemokine receptor is to guide di-
rectional cell migration toward a chemokine concentration gra-
dient. The ability of PA-CXCR4 to control the directional mi-
gration of T cells was first confirmed by repeated illumination at
the cell edge, which produced prolonged cell movement by gen-
erating a consistent, coordinated extension of the leading edge
and retraction of the uropod (Fig. 3D, i, and Movie S6). Moving
the spot of illumination to the uropod position led to the cessation
of cell migration to the previous illumination position, with new
polarized activities appearing where the light spot was placed (Fig.
3D, ii, and Movie S6), demonstrating reversible cell polarization
by light stimulation. We then examined whether the activation of
PA-CXCR4 at the posterior end of a migrating T cell can break
the preexisting cell polarization and reorient the migration (Fig.
3D, iii). Aiming optical stimulation at the tail of a migrating T cell
resulted in new, synchronized lamellipodial initiation at the back
and rapid retraction at the original front, followed by cell move-
ment in the reverse direction using the newly created leading edge
(Fig. 3D, iii, and Movie S7).
In response to external chemokine gradients, chemokine
receptors generate persistent local excitatory signals to guide
directional cell migration (18). Therefore, in contrast to other
photoactivatable proteins, which require light stimulation at or
proximity to the cell membrane to induce cell migration (15, 19),
an important advantage of PA-CXCR4 is its ability to recruit
cells over a long distance toward a light gradient in a way similar
to cell migration along a chemokine gradient. We demonstrated
this by placing diffracted illumination at the center of the cell
migration plate. The illumination of 20-μm or 100-μm spots on
the plate successfully recruited PA-CXCR4–expressing T cells
toward the light gradients, suggesting that the activation of
PA-CXCR4 induces phototaxis (chemotaxis toward a light gra-
dient) (Fig. 3D, iv, and Movies S8 and S9). These results, in
combination with the earlier biochemical data in Fig. 2, support
the conclusion that PA-CXCR4 can be functionally expressed in
T cells to permit the photoactivatable control of chemotactic
signals and to modulate directional cell migration using light.
Optical Control of T-Cell Recruitment in Vivo. The first response of
rolling and tethering T cells to local chemokine stimulation in
vivo is rapid integrin activation and firm adhesion to the blood
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Fig. 3. Activation of PA-CXCR4 induces T-cell polarization and migration in
vitro. (A) Repeated illumination of a mouse CD4+ T cell expressing PA-CXCR4
induced cell membrane protrusions and polarization. A narrow rectangular
region of interest was obtained from each image in the time lapse series and
then pasted in a montage to form the kymograph picture (Lower Right). (B)
The average angle of cell polarization (Right; the angle of the illumination
spot was 0 ± 5° to the cell centroid) and cell length (distance between cell
centroid and membrane protrusion; Left; mean ± SEM; *P < 0.05 compared
with GFP) are shown. (C) GD25 cells were transiently transfected with Rap1
FRET sensor and PA-CXCR4 and illuminated in a 10-μm circle (white) with
505-nm light for 3–5 min. FRET efficiencies before (pre) and after (post) light
stimulation are shown in rainbow colors, from high (red) to low (blue).
Results from five individual experiments were normalized according to the
basal energy transfer. (D) Schematic of in vitro T-cell migration test with
light stimulation (Center). In the images labeled I and ii, the repeated illu-
mination at the edge of mouse CD4 T cells transiently expressing PA-CXCR4
(white arrow) induced directional migration on ICAM-1–coated surface (di-
rected migration), and T cells stopped upon light activation at the uropod
(controlled stop). T-cell migration after controlled stop was quantified
(mean ± SEM; **P < 0.01). In the images labeled iii, reverse polarization was
induced by continuous illumination at the uropod of PA-CXCR4–expressing
mouse CD4 T cells. The percentages of stop and reverse polarization were
quantified (mCherry-expressing T cells, n = 10; PA-CXCR4–expressing T cells,
n = 14). In the images labeled iv, T cells expressing PA-CXCR4-mCherry mi-
grated toward the area of light illumination (phototaxis) (arrowhead). Light
mediated directional T-cell migration was quantified (mCherry, n = 23;
PA-CXCR4, n = 12). Red arrow, direction of cell migration.
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vessel wall, which is followed by crawling and transendothelial
migration. The light-mediated rapid, firm adhesion of PA-
CXCR4–expressing T cells was confirmed in vivo. T cells were
arrested in the femoral vein triggered by local optical stimulation
with 0.48 mW/mm2 light at 488 ± 10 nm (Fig. 4 and Movies S10
and S11). Within seconds of ending the light stimulation, many
adherent T cells quickly detached from the blood vessel, dem-
onstrating the reversibility of the light-mediated activation of
chemokine signals in vivo (Fig. 4 and Movie S10).
In a long-term in vivo T-cell recruitment assay, we attached
a 200-μm cyan light-emitting diode (LED; 25 mW at 505 ± 15
nm) optical fiber onto the hairless area of an unshaven mouse
ear (Figs. S7 and S8). The directional guidance of cell migration
requires chemotactic molecule gradients, with at least 2% dif-
ferences in concentration between the front and back of a cell
(18). To determine whether a stable light gradient was estab-
lished in the ear dermis by the optical fiber to guide T-cell ex-
travasation and migration, we first measured the light propagation
pattern in the mouse ear (Fig. S8A). The light–power density
profiles revealed the gradual attenuation of light intensity in
the mouse ear, both vertically (z direction; Fig. S8B) and hori-
zontally (x–y direction; Fig. S8C). The computed average vertical
light intensity delta corresponded to a 2% decrease every 10 μm
(approximately one mouse T-cell diameter). This result sug-
gests that our in vivo optical stimulation can successfully deliver
a functionally active light gradient for directional T-cell migration
in the dermis.
Using this system, we performed homing assays to assess the
ability of local optical stimulation to regulate chemotactic signals
in PA-CXCR4 cells and to guide cell migration in vivo. In vitro-
activated DO.11 CD4 T cells were transfected with PA-CXCR4
(TPA-CXCR4 cells) and then transferred into recipient mice. Cells
were harvested from freely moving mice following 24, 48, or 72 h
with/without light stimulation. The ratio of TPA-CXCR4 cells in
light:dark inflamed ears (OVA + CFA), spleens, and lymph
nodes (LNs) was assessed. TPA-CXCR4 cells exhibited enhanced
homing to light-activated inflamed ears at 48 and 72 h, whereas
homing to the spleen and LNs was not altered (Fig. 5 A and C).
Conversely, the expression of control vector GFP did not lead to
enhanced CD4 T-cell homing to the light-stimulated ears (Fig.
5B). These data suggest that local light stimulation can suc-
cessfully recruit adoptively transferred PA-CXCR4–expressing
T cells to targeted tissue in vivo.
Optogenetically Engineered T Cells for Cancer Immunotherapy. To
demonstrate the clinical implications of PA-chemokine recep-
tors, we examined the ability of PA-CXCR4 to enhance the ef-
ficient trafficking of adoptively transferred tumor-specific CD8+
T cells toward a tumor site and to improve antigen-specific tu-
mor regression. C57BL/6 mice were injected intradermally in the
ear with B16/OVA tumor cells, which developed solid tumors that
failed to be rejected in the absence of additional manipulation
(Fig. 6A). Similar tumor growth patterns were observed following
the transfer of 1 × 105 in vitro-activated OT-I CTLs. Adoptive
T-cell therapy through the transfer of 1 × 106 OT-I CTLs resulted
in a slight tumor regression but no tumor cell elimination (Fig.
6A). The transfer of 10 times more OT-I CTLs (1 × 107) failed to
induce any detectable changes in tumor regression (Fig. 6A). This
finding suggests the presence of a tumor microenvironment that
suppresses the accumulation of antitumor immune responses by
transferred CTLs (Fig. 6A) (3). Next, we transfected in vitro-ac-
tivated OT-I CTLs with PA-CXCR4 and transferred the resulting
PA-CXCR4+CD45.1+CD8+ OT-I CTLs into B16/OVA tumor-
bearing mice 7 d after tumor cell injection. Subsequently, the
visible and palpable tumor area was illuminated with a cyan op-
tical fiber (505 nm, 3.67 mW/mm2) for 7 d, and tumor growth was
measured for an additional 7 d without illumination. Dark mice
were treated equally for a total of 21 d without light stimulation
(Fig. 6B). Localized light stimulation for 7 d dramatically de-
creased tumor growth in the mouse ear (Fig. 6 C and D). Light
stimulation of the mice that received GFP-transfected OT-I CTLs
did not alter tumor growth, implying that the effect of 505-nm
LED light alone is not detrimental to the tumor cells (Fig. 6E).
Microscopic analyses of B16/OVA tumors confirmed that local
light stimulation resulted in a marked increase in intratumoral
OT-I CTL infiltration, whereas the total CD8+ T-cell numbers
were similar between the dark and light mice (Fig. 6 G and H). At
7 d after the PA-CXCR4+CD45.1+CD8+ OT-I CTLs were trans-
ferred, these cells (CD45.1+) accumulated in multiple discrete
areas both in the periphery and in the core of the B16/OVA
tumors in the presence of light stimulation, without any noticeable
changes in the vascular density (Fig. 6 F and I and Movie S12). In
contrast, PA-CXCR4+ CTLs were mainly found in the pe-
riphery near the tumor microvessels, their likely port of entry,
under the dark condition (Fig. 6 F and I and Movie S13). Our
data suggest that light stimulation of PA-CXCR4 increases not
only the total number of adoptively transferred CTLs but also the
homing of T cells, both in the tumor center and at the periphery,
and thus their local cytolytic reactions.
To further confirm that the change in tumor size was mainly
due to enhanced CTL infiltration and not to the recruitment
of innate effector cells, we measured other leukocyte subtypes
Fig. 4. In vivo T-cell firm adhesion. The firm adhesion of T cells induced by
light stimulation of PA-CXCR4 was visualized in the femoral veins using two-
photon intravital microscopy. Representative images of CFSA-labeled CD4+
T-cell adhesion before (pre) and after (post) light stimulation (Left) are
shown, and the number of adherent cells was measured in three in-
dependent experiments (mean ± SEM; *P < 0.05 compared with GFP-
expressing control T cells).
Fig. 5. In vivo T-cell recruitment. (A) The fold change in the T-cell homing
index, as determined by the light mouse [PA-CXCR4+CD4+/PA-CXCR4−CD4+]/dark
mouse [PA-CXCR4+CD4+/PA-CXCR4−CD4+] ratio. BALB/c mice were infected
in one ear with OVA323–339 peptide emulsified with CFA and subjected to
light activation through an optical fiber, whereas the other ear (control) was
left uninflamed without the optical fiber attached. The horizontal line (red)
indicates a homing index of 1. n = 3 (mean ± SEM; *P < 0.05 compared with
control). LN, cervical lymph node. (B) Homing index of GFP-expressing DO.11
CD4+ T cells. n = 3 (mean ± SEM). (C) Flow cytometry analysis of transferred
cells (CFSE+) in an OVA/CFA-inflamed ear with (light) or without (dark) light
stimulation for 72 h.
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in B16/OVA tumors. Light stimulation did not alter the
number of tumor-infiltrating NK cells (CD3−NK1.1+), mac-
rophages (CD3−NK1.1−CD4−CD8−CD11b+Ly6C−Ly6G−),
polymorphonuclear myeloid-derived suppressor cells (MDSCs)
(CD3−NK1.1−CD4−CD8−CD11b+Ly6G+Ly6Cmid), or monocytic
MDSCs (CD3−NK1.1−CD4−CD8−CD11b+Ly6G−Ly6Chi) (Fig. S9
A and B). The effects of light activation of PA-CXCR4 on the
quality of infiltrated CTLs were then analyzed by real-time PCR
(Fig. S10). The levels of major inflammatory cytokines, including
IL2 and IFN-γ, T-cell proliferation, and effector molecules, such
as granzyme B and perforin, were substantially increased in the
adoptively transferred CTLs after light stimulation (Fig. S10),
suggesting that the enhanced trafficking of PA-CXCR4+ CTLs by
light stimulation can improve the quality of T-cell responses by
promoting local effector functions and antitumor activity.
Discussion
Efficient migration of newly transferred cells to targeted tissues
is the most critical step for achieving optimal outcomes in the
ACT therapy. For example, monitoring of transferred CTLs af-
ter ACT has shown that most infused CD8+ T cells localize to
the lung, liver, or spleen, whereas only ∼1% of the total trans-
ferred T cells migrate to the tumor (3, 20). In addition, the
majority of adoptively transferred CD8+ T cells are preferentially
found in the tumor periphery allowing time for escape mechanisms
to be enacted in the central regions of the tumor (21, 22). In this
study, we developed a photoactivatable chemokine receptor that
leverages common structure–function relationships between two
different GPCR families (rhodopsin receptor and chemokine
receptor). PA-CXCR4 can recruit distinct T-cell populations in
vivo by inducing migration signals in response to light, demon-
strating that a highly selective localized chemokine signal is
sufficient to recruit transferred cells to the targeted tumor in vivo
and thereby elicit effective tumor rejection. Consistent with our
findings, activation of endogenous G protein pathway using blue
opsin resulted in similar cell migration in neutrophil by light
stimulation (15). Direct illumination on the blue opsin-express-
ing cell surface was sufficient to generate a diffusible gradient of
intracellular signaling molecules, such as phosphatidylinositol
(3,4,5)-triphosphate.
Many types of tumors can actively prevent T-cell infiltration by
modifying gene expression of adhesion molecules such as ICAM-1
and VCAM-1 in vascular endothelial cells (21) or by inducing
posttranslational modification of local chemokine signals, in-
cluding CCL2 (23). Our data are in agreement with several
strategies that have been proposed to optimize antitumor T-cell
migration by transducing highly targeted, localized chemokine
signals at the tumor site. Furthermore, recent studies have dem-
onstrated that adoptively transferred CD8 T cells are recruited to
a s.c. EG7-thymoma model, yet remain in its periphery (22, 24). In
the present study, stimulation of PA-CXCR4 with light increased
the recruitment of adoptively transferred OT-I T cells and enabled
them to migrate into the core of B16 tumors, leading to signifi-
cantly enhanced tumor rejection. Because T cells were unable to
improve their tumor infiltration under the dark condition and
because the endogenous CD8 responses and intratumor vascular
structures were unmodified, the effects of light stimulation were
likely directly related to the recruitment (and positioning) of the
transferred T cells.
Our photoactivatable chemokine receptor provides a unique
opportunity to investigate the dynamic changes in polarized in-
tracellular biochemical signals that mediate accurate lymphocyte
chemotaxis, as light could be delivered to a very small and well-
defined area in precisely timed pulses, and may enable optical
control of other chemokine receptors with similarly designed
constructs. However, it is important to note that for individual
PA-chemokine receptors, it may not be possible to control of all
of the receptor conformational states that are necessary to
generate signals identical to those induced by the WT receptor–
ligand interaction. Indeed, the trend of receptor signals (in-
cluding calcium concentration and up-regulation of both pAkt
and pPAK1) was similar for both CXCL12 and light stimulations
in WT and PA-CXCR4 T cells, but the peak response was
delayed in PA-CXCR4–expressing cells, suggesting distinct sig-
naling kinetics. Dimerization or oligomerization of GPCR is a
recognized mode of regulation of receptor activities and signal-
ing functions. CXCR4 has been previously shown to homodi-
merize and heterodimerize, constitutively and upon ligand binding
(25, 26). Unlike other GPCR dimerization, which depends on
contacts throughout the transmembrane (TM) bundle, CXCR4
monomers interact only at the extracellular side of helices V and
Fig. 6. Optical control of CTL migration in antitumor immunotherapy. (A)
Antigen-specific tumor regression upon adoptive transfer of in vitro-primed
CTLs. (B) Experimental design of the studies of the optical control of CTL
migration. (C) Growth curves of B16/OVA tumors in mice treated with ACT of
PA-CXCR4–expressing OT-I CD8+ T cells with (optical fiber + light) or without
(optical fiber + dark) light stimulation. The light stimulation (505-nm) times
are denoted with a green box. n = 5 mice per condition (mean ± SEM; *P <
0.01 compared with dark). (D) The percent change in tumor volume (com-
pared with day 7). (E) Growth curves of B16/OVA tumors in mice treated
with ACT of GFP-expressing OT-I CD8+ T cells with (optical fiber + light) or
without (optical fiber + dark) light stimulation. n = 5 mice per condition
(mean ± SEM). (F) Representative immunofluorescence images of B16/OVA
tumors in mice treated with the ACT of PA-CXCR4–expressing OT-I CD8+ T
cells with (light) or without (dark) light stimulation (on day 14). The data are
representative of more than three independent imaging experiments. (G
and H) Quantification of total PA-CXCR4–expressing CTLs (CD45.1+) com-
pared with the total CD8+ T-cell numbers in B16/OVA tumors by microscopy.
n = 3 (mean ± SEM; *P < 0.01 compared with dark). (I) CD45.1+ cell location
throughout the depth of the tumor.
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VI (7). Although the biological function of CXCR4 dimerization
remains incompletely characterized, a considerable body of data
suggests important in vivo effects (25-27). The extracellular and
the TM domains in PA-CXCR4 were originated from rhodopsin
and thus may not support the specific receptor dimerization seen
in WT CXCR4. Therefore, it is possible that lack of the receptor–
receptor interactions may result in delayed signaling responses
seen in some of our assays, although we cannot discount the
possibility that new modes of dimerization may exist in PA-
CXCR4, which may cause different signaling kinetics.
In vivo, different chemokines may cooperate temporally and
spatially to control the movement of T cells and to prioritize
their responses to the different chemokines present in the
inflamed tissues. Once T cells recognize a certain pair of che-
mokine signals (including the PA-CXCR4 signal) at the tissue
site, they can respond specifically, even overcoming an opposing
chemokine gradient coming from the other vasculatures. Some
chemokine receptors may become sensitized or desensitized by
the interactions, allowing a certain group of chemokine receptors
to dictate the T-cell migration. Alternatively, a hierarchical re-
sponse may take place in a sequential manner, in which PA-
CXCR4 initially dominates over other end-target chemokine
signals so that T cells move along a light gradient; this signal is
then ignored (or desensitized), and the T cells follow a new
gradient of local chemokine receptor ligands, thus gaining access
to a precise tissue site. The synergistic interactions between
different chemokine receptors may not only affect T-cell migra-
tion, but it is also possible that certain types of chemokines work
collaboratively to mediate T-cell retention at the tissue. Addi-
tionally, emerging evidence indicates that CXCR4 concurrently
provides multiple signals to induce migration while simulta-
neously preparing the cell for its destination, the site where this
chemokine drives T-cell development and cytokine secretion and
regulates cell apoptosis (28, 29). Therefore, it is possible that an
increase in the T-cell number at a tissue site following the local
light stimulation of PA-CXCR4 may result from the integration
of multiple outcomes of CXCR4 signaling in vivo. The levels of
certain inflammatory cytokines and effector molecules were
significantly increased in the adoptively transferred T cells after
light stimulation, suggesting additional effects of PA-CXCR4
on the quality and magnitude of the T-cell response.
Materials and Methods
To apply light illumination to mouse T cells in vivo, a Nikon Eclipse TE2000-E
microscope (Nikon) was equipped with Mosaic microelectromechanical sys-
tems (MEMS) Digital Mirror Device (Andor Technology). PA-CXCR4-mCherry–
expressing mouse T cells and GFP-expressing mouse T cells were generated
using a retroviral expression system, as described above. The cells were then
resuspended in L15 medium (Gibco) containing 2 mg/mL glucose (Sigma) at
4 °C and placed on a mouse ICAM-1–coated Delta T dish (Bioptechs). The cell
edge was activated using light (505 nm, 2-μm diameter) in a 30-s light/30-s
dark cycle. Time lapse images were acquired at room temperature or at 37 °C.
Image acquisition and analysis were performed using NIS-Element software
(Nikon). Detailed methods may be found in SI Materials and Methods.
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